Agrify CorporationAgrify Corp • February 28th, 2024 • Agricultural services • New York
Company FiledFebruary 28th, 2024 Industry Jurisdiction
Agrify CorporationAgrify Corp • February 14th, 2024 • Agricultural services • New York
Company FiledFebruary 14th, 2024 Industry Jurisdiction
Agrify CorporationAgrify Corp • February 8th, 2024 • Agricultural services • New York
Company FiledFebruary 8th, 2024 Industry Jurisdiction
Adamis Pharmaceuticals Corporation 8-KAdamis Pharmaceuticals Corp • August 3rd, 2023 • Pharmaceutical preparations • New York
Company FiledAugust 3rd, 2023 Industry JurisdictionThis letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (the “Placement Agent”) and Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), that the Placement Agent shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) to certain purchasers (the “Purchasers”) of up to an aggregate of (i) 4,800,000 common units (each a “Common Unit” and collectively, the “Common Units”), with each Common Unit consisting of (A) one share (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), (B) one common stock purchase warrant (each a “Warrant” and collectively, the “Warrants”) to purchase one share of Common Stock (the “Warrant Shares”) exercisable immediately and expiring five years after the date of issuance at an exercise price of $1.35 per share of Common Stock, and (ii) 1,130,
Adamis Pharmaceuticals Corporation S-1Adamis Pharmaceuticals Corp • July 13th, 2023 • Pharmaceutical preparations • New York
Company FiledJuly 13th, 2023 Industry JurisdictionThis letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (the “Placement Agent”) and Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), that the Placement Agent shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) to certain purchasers (the “Purchasers”) of up to an aggregate of (i) [___] common units (each a “Common Unit” and collectively, the “Common Units”), with each Common Unit consisting of (A) one share (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), (B) one common stock purchase warrant (each a “Warrant” and collectively, the “Warrants”) to purchase one share of Common Stock (the “Warrant Shares”) exercisable immediately and expiring five years after the date of issuance at an exercise price of $[__] per share of Common Stock, and (ii) [____] pre